Medical Injection Molding Case Evidence

Medical Injection Molding Case Studies: CTQ, Validation & Quality Evidence

Three project examples showing how CTQ definition, inspection records, material traceability and validation-support evidence are reviewed during medical molding development.

Medical injection molding case evidence review with CTQ inspection and quality documentation

These medical injection molding case studies focus on the manufacturing evidence engineering and sourcing teams typically review when a molded component includes sealing surfaces, thin-wall geometry, fit-critical interfaces, overmold boundaries or traceability requirements.

The three examples cover a catheter connector, a thin-wall drug-delivery housing and a two-shot medical component. Each case connects the identified project risk to the relevant CTQ, inspection method and supporting records, including drawing-based FAI, dimensional or optical inspection, material documentation and trial-stage evidence where specified.

For broader material selection, tooling decisions and supplier-risk considerations, review our medical plastic injection molding requirements . For production capacity and process options outside these project examples, see our injection molding services .

Project Comparison

Case Evidence Overview

Each case is organized around the project condition, the CTQ that required control, the inspection method used to evaluate it and the evidence available for engineering review.

Summary of medical injection molding case projects, CTQ requirements, inspection methods and evidence reviewed.
Case Project Resin / Process Review CTQ Focus Inspection Method Evidence to Review
Catheter Connector Specified resin and overmolding compatibility review Sealing diameter, tubing-retention area, overmold interface and potential leak-path geometry Dimensional inspection, interface review and leak or pressure verification where specified FAI Trial Record Material Cert
Drug-Delivery Housing Resin behavior, thin-wall stability and feature-fill review Sealing-face flatness, snap-fit position, micro-feature definition and assembly alignment Optical measurement, CMM inspection, feature review and drawing-based FAI where required Material Cert CoC FAI
Two-Shot Medical Component Two-shot molding review for rigid-soft interface and shot-to-shot alignment Interface consistency, flash control, assembly fit and material-traceability boundary Assembly-force check, fit verification, interface inspection and traceability review Lot Traceability Validation Support CoC

Validation scope: This page shows project-level evidence rather than a complete mold-validation procedure. For the broader validation framework, see the injection mold validation guide .

Medical Molding Case 01

Catheter Connector Overmolding with Sealing Interface Control

Catheter connector overmolding case showing sealing interface and tubing-retention geometry
Sealing interface, tubing-retention geometry and overmold coverage identified as functional CTQ areas.

Project Background & Functional Risk

This project involved a disposable catheter connector with a molded connection interface and an overmolded grip area. The engineering review concentrated on the interfaces that could influence sealing, tubing retention, assembly fit and overmold consistency rather than treating all molded features as equal-risk dimensions.

Critical-to-Quality Features

Before tooling release, the functional interfaces were separated from general cosmetic dimensions and identified as Critical-to-Quality (CTQ) features. The review focused on:

  • Sealing diameter: mating diameter, roundness and datum relationship against the drawing and interface requirements.
  • Tubing-retention geometry: barb definition, pitch consistency and areas where flash could affect assembly or retention.
  • Overmold interface: coverage, flash, void or incomplete-fill risk and other conditions that could affect the functional interface.
  • Functional retention: pull-off or mechanical-retention criteria only where a customer-defined test method and acceptance limit were specified.
Catheter connector inspection fixture for sealing interface and leak-path verification
Inspection-fixture concept for sealing-interface verification where functional testing was specified.

Manufacturing Review & Process Response

The molding review covered substrate and overmold compatibility, resin handling, the bonding-interface condition, gate and venting strategy, flash-sensitive geometry and the records required to preserve material and production traceability. These reviews were tied back to the CTQ interfaces rather than treated as independent process checks.

Inspection & Evidence Package

The inspection plan prioritized evidence connected to sealing, tubing retention, overmold coverage and traceability. Depending on drawing and customer requirements, the review could include:

  • Dimensional FAI: sealing diameter, retention geometry, interface dimensions, overmold coverage and drawing revision.
  • Functional verification: leak, pressure or retention testing only where the customer supplied the test method and acceptance criteria.
  • Material and lot records: material certificate, resin lot, cavity or production identification and drawing revision where required.
  • Trial-stage evidence: tooling observations, flash or coverage issues and documented corrective actions retained through the agreed trial history.
Functional Risk Sealing, tubing retention and overmold-interface consistency
Primary CTQ Sealing diameter, retention geometry and overmold coverage
Evidence Dimensional FAI, material records and specified functional checks
Engineering Lesson Functional interfaces should be defined before tooling decisions are frozen
Evidence boundary: device-level acceptance criteria, leak or pressure limits, retention limits, sterilization requirements and regulatory validation remain customer-defined. SPI's scope in this case is manufacturing-feasibility review, tooling and molding support, inspection evidence, traceability records and agreed validation-support documentation.
Medical Molding Case 02

Thin-Wall Drug-Delivery Housing with Micro-Feature & Fit Control

Thin-wall drug-delivery housing under optical inspection for micro-features and fit-critical CTQ areas
Optical inspection focused on micro-features, snap-fit geometry and fit-critical molded interfaces.

Project Background & Functional Risk

This case involved a drug-delivery housing with thin-wall sections, small molded features, snap-fit interfaces and fit-critical alignment surfaces. The engineering review focused on dimensional shift, warpage, incomplete filling, flash and tolerance interaction because these conditions could affect assembly fit and interface alignment even when the molded part appeared visually acceptable.

Critical-to-Quality Features

Before tooling release, the drawing and assembly interfaces were reviewed to identify the features that required CTQ-level control. The primary areas were:

  • Sealing face and snap-fit interfaces: flatness, engagement geometry and interface location relative to the drawing datum structure.
  • Micro ribs and alignment bosses: feature definition and areas susceptible to incomplete fill, flash or gas-trap conditions.
  • Tolerance interaction: mating dimensions reviewed together so an individual dimensional pass would not conceal an assembly-fit or alignment problem.
  • Warpage-sensitive geometry: thin-wall sections, wall transitions and fit-critical surfaces where molding variation could shift the functional interface.

Tooling & Process Response

The tooling and molding review concentrated on the process conditions most closely connected to those CTQs. Gate position and flow direction were reviewed against thin-wall sections and small features, while venting attention was directed toward rib ends, bosses and flow-end regions. Thermal balance, resin flow behavior and trial-stage defect observations were then considered when deciding whether a tooling or process correction was required.

Inspection & Evidence Package

Inspection methods were selected according to feature size, accessibility, datum structure and drawing requirements rather than assigning one metrology method to every feature. The project evidence could include:

  • Optical inspection: small-feature definition, flash-sensitive regions, snap-fit geometry and other visually accessible CTQs.
  • Dimensional metrology: CMM, optical measurement or fixture-based checks selected according to datum logic and feature access.
  • Drawing-based FAI: fit-critical dimensions, sealing surfaces, alignment features and drawing-revision status where required.
  • Traceability records: material documentation, CoC, trial-stage notes and production records only where supported by the actual project scope.
Functional Risk Thin-wall variation, warpage and fit-critical interface shift
Primary CTQ Sealing faces, snap fits, micro-features and alignment geometry
Evidence Optical inspection, dimensional FAI and traceability records
Engineering Lesson Visual acceptance alone does not confirm functional interface conformity
Medical Molding Case 03

Two-Shot Medical Component with Rigid-Soft Interface Control

Two-shot medical molding case showing rigid-soft interface alignment and process review
Two-shot molding review focused on interface alignment, material transition and repeatability.

Project Background & Interface Risk

This case involved a syringe-related multi-material component with a rigid body and a soft functional interface. The main engineering risk was not simply molding two materials in one part, but maintaining shot-to-shot alignment, interface consistency, flash control and assembly-fit behavior across the rigid-soft transition.

Critical-to-Quality Features

The project review identified the interface conditions most likely to influence assembly and function and treated them as CTQ features:

  • Interface alignment: shot-to-shot registration and positioning at the rigid-soft transition.
  • Locking features: engagement geometry linked to the drawing datum structure, assembly intent and customer-defined acceptance requirements.
  • Material transition: continuity of the rigid-soft boundary, flash, incomplete fill and other visible or functional interface defects.
  • Specified soft-material condition: hardness and surface characteristics controlled against the approved material specification rather than subjective tactile judgment.
  • Assembly function: retention, engagement or release behavior only where a customer-defined test method and acceptance criterion were provided.
Two-shot medical component showing rigid-soft transition and flash-sensitive locking interface
Rigid-soft transition, locking geometry and flash-sensitive interface reviewed as functional CTQs.

Two-Shot Process Response

The manufacturing review linked material pairing, part positioning and second-shot alignment back to the defined interface CTQs. Trial-stage observations were used to review fill condition, flash, registration and interface stability before production-intent release, with tooling or process correction considered where those observations affected the agreed requirements.

Inspection, Traceability & Change Control

The evidence package connected interface quality with dimensional inspection, material traceability and revision control. This was important because a change to material, tooling or process conditions could affect both shot alignment and rigid-soft interface behavior.

  • Interface inspection: flash, registration, transition condition and visible interface defects reviewed against the agreed drawing or project criteria.
  • Dimensional inspection: CMM, optical measurement or fixture-based checks selected according to feature accessibility, datum structure and drawing requirements.
  • Material and lot traceability: material lot, production identification, tooling revision and drawing revision linked through the agreed manufacturing records where required.
  • Engineering change control: tooling, material, process or acceptance-criteria changes reviewed before release under the agreed production-control process.
Functional Risk Shot alignment, flash and rigid-soft interface inconsistency
Primary CTQ Interface registration, locking geometry and transition quality
Evidence Interface inspection, dimensional records and material traceability
Engineering Lesson Multi-material molding must control the interface, not only each individual material
Evidence & Responsibility Boundary

Medical Molding Scope: Manufacturing Support vs. Device-Level Responsibility

The case studies above document manufacturing risks, CTQ review, inspection, traceability and agreed project records. They do not replace the customer's device-level design, regulatory or final product responsibilities. Keeping that boundary clear prevents manufacturing evidence from being interpreted as device approval.

SPI Manufacturing Scope

Manufacturing & Quality Evidence

  • Tooling and molding feasibility review against the agreed drawing, CTQs and project requirements.
  • Dimensional and visual inspection against defined datums, drawings and inspection requirements.
  • Material, production, cavity, tooling or revision traceability where included in the agreed scope.
  • FAI, dimensional reports, material certificates, CoC and other manufacturing records where required and supported by the project.
  • Trial-stage and validation-support documentation only where specifically defined for the program.
Customer / OEM Scope

Device-Level Decisions & Acceptance

  • Final device design, intended use and device-level risk-management decisions.
  • Regulatory strategy, submissions, registrations and product-approval decisions.
  • Final device verification, validation and product-safety acceptance.
  • Sterilization, biocompatibility and other end-use qualification requirements.
  • Final acceptance criteria and legal-manufacturer responsibilities applicable to the finished device.
Scope clarification: the exact inspection, traceability and documentation package depends on the customer's drawing, quality requirements, purchase documentation and approved project scope. The manufacturing evidence shown on this page should therefore be read as project-level production support, not as device-level regulatory approval.
RFQ & Case Review

FAQ for Medical Molding Case Review & RFQ Preparation

These questions focus on the information needed to compare a new medical molding project with the case evidence above and prepare a more complete engineering or quotation review.

RFQ Input

What files should be submitted before a medical injection molding RFQ?

A useful RFQ package normally includes the current 3D CAD model, revision-controlled 2D drawing, specified resin, estimated production volume, tooling intent and clearly identified CTQs. Fit-critical interfaces, sealing surfaces, overmold boundaries and inspection requirements should be marked before DFM and quotation review.

CTQ Definition

Which requirements should be identified as CTQs before tooling release?

CTQs should be tied to functional risk rather than every drawing dimension. Examples from the cases above include sealing diameters, snap-fit geometry, alignment features, overmold interfaces and rigid-soft transitions. The drawing, datum logic and inspection method should make each agreed CTQ measurable and reviewable.

Supplier Evidence

What evidence can buyers review before supplier approval?

The evidence should connect the drawing and CTQs with manufacturing and inspection records. Depending on project scope, this can include DFM or trial notes, dimensional FAI, CMM or optical inspection results, material certificates, CoC, traceability records and revision-controlled documentation. Claims should be supported by actual project records.

Production Route

When should a project avoid moving directly into production tooling?

Production tooling may be premature while geometry, mating interfaces, resin, CTQs or expected volume are still changing. In that situation, the next decision is not explained on this case page; compare the available prototype, bridge and production routes before committing to the production mold.

RFQ scope: project requirements should come from the approved drawing, material specification and customer quality requirements. The examples on this page show manufacturing evidence and review logic; they do not establish device-level regulatory or final functional acceptance criteria.
Prepare Your Project

Request a Medical Injection Molding Engineering Review

If your project has defined geometry, material requirements and functional CTQs, send the available design and production information for manufacturability, tooling and inspection review. The more clearly the critical interfaces and evidence requirements are defined, the more focused the engineering review can be.

Helpful RFQ inputs
  • 3D CAD model
  • Revision-controlled 2D drawing
  • Specified resin
  • Critical tolerances / CTQs
  • Estimated production volume
  • Tooling intent or project stage
  • Inspection requirements
  • Required quality documents